Gene-based therapies in Parkinson's disease

Area of Science:

• Neurology
• Neuroscience
• Genetics

Background:

• Parkinson's disease (PD) involves the degeneration of dopamine-producing neurons, leading to motor and non-motor symptoms.
• Current treatments like levodopa manage symptoms but have limitations and do not halt disease progression.

Purpose of the Study:

• To review past and current gene therapy clinical trials for Parkinson's disease.
• To explore novel preclinical gene therapy approaches for PD.

Main Methods:

• Review of human clinical trials for gene therapy in PD.
• Description of preclinical gene therapy research for PD.

Main Results:

• Gene therapies for PD have entered human clinical trials over the last decade.
• Clinical trial results are mixed, but therapies are generally safe and well-tolerated.

Conclusions:

• Gene therapy shows potential as a future treatment for Parkinson's disease.
• Further research into gene therapy may offer symptomatic and disease-modifying benefits for PD.